Omnicare ( OCR ): Q1 EPS of $0.90 beats by $0.05 . Revenue of $1.53B misses by $0.01B . ( PR ) Post your comment!
names David W. Froesel, Jr. as interim Chief Financial Officer , effective immediately. Mr. Froesel, who was CFO of Omnicare from 1996 to 2009, and succeeds Michael J. Culotta, who by mutual agreement with the company, has stepped down to
Omnicare ( OCR -0.6% ) slips despite a Q4 earnings beat across the board. Net earnings rose 89% as the nursing-home pharmacy company benefited
My name is Brant, and I will be your conference operator today. At this time, I would like to welcome everyone to Omnicare 's Fourth Quarter and Year End Conference Call. All lines have been placed on mute to prevent any background noise
Omnicare ( OCR ): Q3 EPS of $0.86 beats by $0.13 . Revenue of $1.5B (-2.8% Y/Y) misses by $40M . ( PR ) Post your comment!
Sept 26 (Reuters) - Moody's assigns Baa3 ratings to Omnicare 's amend and extend bank credit facilities; outlook stable
Omnicare ( OCR ) yesterday named interim CEO John Workman to the top job permanently ..... nursing homes with drugs, and so he'll be replaced by Robert Kraft. Omnicare also doubled its dividend to $0.14 a share and increased its buyback
June 11 (Reuters) - Pharmacy operator Omnicare Inc said Chief Executive John Figueroa resigned, and it named finance chief John Workman as interim CEO.
investigations into how it marketed its Risperdal antipsychotic treatment and other drugs, and claims it paid kickbacks to Omnicare ( OCR ), Bloomberg reports. Unlike with the banks, J&J will make a misdemeanor plea, with the deal including a criminal
May 11 (Reuters) - Pharmacy operator Omnicare Inc said it will pay $50 million to settle an investigation by the U.S. Department of Justice (DoJ) concerning errors in the company's distribution of controlled substances.